Article
Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.
PloS one - 1 Jan 2013
Ueda Yoshihide, Kaido Toshimi, Ogura Yasuhiro, Ogawa Kohei, Yoshizawa Atsushi, Hata Koichiro, Fujimoto Yasuhiro, Miyagawa-Hayashino Aya, Haga Hironori, Marusawa Hiroyuki, Teramukai Satoshi, Uemoto Shinji, Chiba Tsutomu
Abstract excerpt
BACKGROUND: Given the limited efficacy and high adverse event rate associated with treatment of recurrent hepatitis C after liver transplantation, an individualized treatment strategy should be considered. The aim of this study was to identify predictors of response to antiviral therapy for hepatitis C after living donor liver transplantation (LDLT) and to study the associated adverse events. METHODS: A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
